This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Rescue Hearing Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations in Gene Therapy by Caesar James Ayala
Introduction
Caesar James Ayala is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of hearing loss. His innovative work focuses on addressing genetic mutations that lead to deafness, showcasing his commitment to advancing medical science.
Latest Patents
Ayala holds a patent for "Gene therapy systems and related methods for treatment of hearing loss." This patent describes gene therapy systems and methods that are useful for treating and preventing deafness caused by genetic mutations of the TMPRSS3 gene or the LOXHD1 gene. The disclosed compositions and methods utilize adeno-associated viral (AAV) vector gene delivery to restore the activity of these genes in the inner ear. This innovative approach aims to promote hair cell survival and restore hearing in patients suffering from hearing loss.
Career Highlights
Ayala is associated with Rescue Hearing Inc., where he continues to develop groundbreaking therapies for hearing loss. His work is characterized by a strong focus on molecular therapeutics and the integration of gene therapy with cochlear implants, which enhances the potential for restoring hearing in affected individuals.
Collaborations
Ayala collaborates with notable colleagues, including Hinrich Staecker and Xue Zhong Liu. Their combined expertise contributes to the advancement of research and development in the field of auditory health.
Conclusion
Caesar James Ayala's innovative contributions to gene therapy represent a significant advancement in the treatment of hearing loss. His dedication to improving patient outcomes through scientific research is commendable and highlights the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile